Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5026 USD | -0.48% | +15.51% | -52.15% |
May. 28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
May. 14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 13.68M | Sales 2025 * | 21.9M | Capitalization | 4.28M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 3M | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.2 x |
P/E ratio 2024 * |
-6.31
x | P/E ratio 2025 * |
5.05
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.09% |
Latest transcript on Evoke Pharma, Inc.
1 day | +6.32% | ||
1 week | +16.90% | ||
Current month | +6.32% | ||
1 month | +4.02% | ||
3 months | -22.31% | ||
6 months | -63.41% | ||
Current year | -51.92% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.5026 | -0.48% | 5 521 |
24-06-03 | 0.505 | +6.32% | 29,738 |
24-05-31 | 0.475 | +10.21% | 11,455 |
24-05-30 | 0.431 | -4.12% | 11,977 |
24-05-29 | 0.4495 | +3.31% | 43,512 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.92% | 4.28M | |
+42.60% | 748B | |
+33.16% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.00% | 245B | |
+8.86% | 211B | |
-4.29% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- EVOK Stock